Primary Recommendation

Medica - Fast growing provider of teleradiology services looks very cheap

November 2018

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Medica is the UK’s largest provider of outsourced teleradiology services in which complex images (such as CT or MRI scans) are sent from a hospital to an offsite consultant radiologist for remote interpretation. Typically, using traditional technology, an NHS patient might have to wait a month before receiving their scan results, but Medica can provide this information in just 20 minutes while also alleviating backlogs and improving NHS productivity.With growth in hospital admissions and increased cancer diagnoses feeding a 50% jump in CT and MRI scans since 2013, Medica has increased pretax profit from £4.9m to £9.4m between FY’14-’17 and the outlook remains strong with Investec forecasting eps of 7.6 ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Swallowfield - Personal care brands to reach 70% of enlarged profit by 2020

Goodwin - Family-run engineer eyes recovery in oil & gas markets

Medica (June 2023)

Medica (June 2021)

Medica (December 2020)

Medica Group (September 2020)

Medica Group (May 2020)

Medica Group (September 2019)

Medica Group - Net debt eliminated (May 2019)

Medica Group (April 2019)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X